The transaction was led by the venture capital firm Invivo Capital, with the participation of the current investors, the Josep Carreras Leukemia Foundation and the Centre for Technological Development...
BHV Partners has opened a seed funding round of €2.5 million to accelerate its growth as a venture builder specialising in creating start-ups in the health sector. The round is aimed at family offic...
Marsi Bionics, la empresa que nació en 2013 como spin off del CSIC para desarrollar el primer exoesqueleto pediátrico del mundo con movilidad 360, acaba de cerrar una operación de ampliación de ca...
Bio & Tech Smart Capital FCRE, fondo de capital riesgo privado promovido por el Grupo Zendal, el empresario gallego CEO de MESTRELAB Santiago DomÃnguez y Noso Capital SGEIC, acordó la inversión de ...
El vehÃculo de inversión Biozell Ventures, asociado a la comunidad Life Sciences Biohub VLC situada en La Marina de València, ha anunciado que participará en la ronda de inversión de Tetraneuron,...
Orikine Bio, a biotech company developing a novel proprietary platform for cytokine-based therapies for autoimmune and inflammatory diseases, announces today the successful closing of a €5.5m seed f...
The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes a collective investment campaign of up to 2 million on the Capital C...
We Venture Capital is the venture capital arm of Werfen, committed to investing in diagnostics start-ups, as well as digital solutions and biotechnology, surrounding the diagnostics space.
The 1st generation of companies participating in BCN Health Booster accelerator raised €51.8 million of public and private funding during 2022 (the first year of its launch), a figure that represent...